12/08/2025
๐จ
The BioStabilization Systems (BoSS) program is seeking breakthrough approaches in cell preparation (TA1) and bioprocessing systems (TA2) that can maintain cell potency and expand access to advanced therapies.
๐๏ธ Solution summaries due:
TA1/TA2: Feb. 19, 2026
IV&V Partner: Apr. 17, 2026
Learn what ARPA-H is looking for and how EverGlade can support your submission strategy: https://hubs.ly/Q03XbZnK0